Is it true that: The GLP-1 pill works exactly as well as the injection.

Myth: The GLP-1 pill works exactly as well as the injection.

The claim

“The GLP-1 pill works exactly as well as the injection.”

Strong evidenceProven in peopleRung 2 of 8 · Supported but limitedDepends which pill — an oral-semaglutide pill is close to the shot; the orforglipron pill is more modest.

What the evidence shows

There are now approved pills. The oral-semaglutide weight-loss pill (oral Wegovy) produced about 16-17% average loss when taken as directed in its OASIS 4 trial — in the same ballpark as the semaglutide injection (~15% in STEP 1). The orforglipron pill (Foundayo) is more modest at about 11% in ATTAIN-1. So "the pill" isn't one thing.

What we still don’t know

These come from separate trials, not head-to-head comparisons, so exact rankings are uncertain. Real-world results also hinge on adherence and, for some oral versions, strict empty-stomach timing rules — the "as directed" figure can outrun everyday use. Long-term and outcome data for the newest pills are still maturing.

Why the claim misleads

"Exactly as well" flattens real differences: an oral-semaglutide pill is genuinely close to its own injection, but a different pill (orforglipron) delivers less on average, and adherence/timing can widen the gap. The honest answer is "some pills come close, not all pills are equal."

Source: Novo Nordisk — FDA approves oral Wegovy (oral semaglutide 25 mg); ~16.6% mean loss when adherent (OASIS 4). Dec 2025.

Graded by The Peptide Era · evidence, not hype